VANCOUVER, BC — The United States Patent and Trademark Office (USPTO) granted patent No. 18/1729,658 entitled “Contact-Free Breath Analysis Device and Method” to Cannabix Technologies Inc.
This patent is centered on innovations made by Cannabix and its dual mode contactless (and traditional mouthpiece) breath capture and analysis technology used inside the company’s BreathLogix device platform. The technology can be integrated into everyday environments such as vehicles, workplaces, or public kiosks, and it supports fast testing without requiring physical contact. The technology can be used in unmanned breath devices; it offers real-time feedback through visual indicators and displays. The system adjusts its internal airflow and pump mechanisms based on the sampling method.
Related Articles:
